Supplements

Guidelines in Practice supplements provide expert opinion articles on a range of clinical and commissioning areas. Our supplement range includes the following types: Product Review; Guidance Update; Local Implementation. Items may contain pharmaceutical promotional information.

Prolia Osteoporosis Bone Health Online supplement_index image

Patient consultation guide—supporting the management of patients with osteoporosis

Commissioned by Amgen Ltd

This promotional supplement has been commissioned by Amgen and developed in partnership with Guidelines in Practice. Information for UK healthcare professionals only.
View Prolia® (denosumab) prescribing and adverse event reporting information
GB-PRO-0222-00034 March 2022

Colitis supplement Index image

Identification and management of colitis in primary care—practical tips and considerations

Commissioned and funded by Ferring Pharmaceuticals

This supplement has been commissioned and funded by Ferring Pharmaceuticals and developed in partnership with Guidelines in Practice
View prescribing and adverse event reporting information for Cortiment® (budesonide) and Pentasa® (mesalazine)
UK-GAS-2100137 December 2021

FINAL Obesity supplement image cover

Overcoming challenges in managing obesity in primary care

Funded by Novo Nordisk Limited

Information intended for UK healthcare professionals only. This supplement has been funded through an arm’s-length sponsorship by Novo Nordisk Limited. Guidelines in Practice approached Novo Nordisk Limited to fund the production of the supplement.
Date of preparation: December 2021

NICE AF RTD - digital

NICE atrial fibrillation: diagnosis and management guideline (NG196) update—treatment considerations for direct-acting oral anticoagulants (DOACs)

Commissioned by Bayer Plc

Information intended for UK healthcare professionals only. This round-table discussion supplement has been commissioned and funded by Bayer plc and developed in partnership with Guidelines in Practice.
View Xarelto® (rivaroxaban) adverse event reporting and prescribing information
PP-XAR-GB-2369
Date of preparation: November 2021

Front cover image

The unrecognised epidemic of vitamin D deficiency in Black, Asian and Minority Ethnic (BAME) groups: a consensus document

Commissioned by STADA incorporating Thornton & Ross

Information intended for UK healthcare professionals only. This supplement has been commissioned and funded by STADA incorporating Thornton & Ross, who provided the content.
TR-088d  Date of preparation: August 2021

Index image

Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes

Supported by an educational grant from Sanofi Ltd

This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd

Front cover 20201202 Plenvu supplement December 2020 PI

Real-world usage study and survey of oral bowel cleansing for colonoscopy in Dudley, UK

Commissioned by Norgine Pharmaceuticals Limited

This supplement has been commissioned by Norgine Pharmaceuticals Limited and contains promotional information. Information for healthcare professionals only.
Click here for PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, potassium chloride, sodium chloride) Prescribing and Adverse Event Reporting.
Click here for MOVIPREP® ((macrogol 3350, sodium sulfate anhydrous, ascorbic acid, sodium ascorbate, sodium chloride, and potassium chloride) Prescribing and Adverse Event Reporting.
Click here for KLEAN-PREP (macrogol 3350, anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride) Prescribing and Adverse Event Reporting.
UK-GE-PLV-2000027
Date of preparation: February 2021

Diabetes equipment vector

Showcasing local best practice in diabetes

This Guidelines in Practice supplement aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care:

Malnutrition supplement

Identification and management of patients with malnutrition

Commissioned by Alliance Pharmaceuticals Ltd

This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.

Biosimilar insulin WPG

Guideline for the managed introduction of biosimilar basal insulin

Supported by an educational grant from Mylan

This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.